These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 22721997

  • 1. Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes.
    Hsieh WL, Lin YK, Tsai CN, Wang TM, Chen TY, Pang JH.
    J Dermatol Sci; 2012 Aug; 67(2):140-6. PubMed ID: 22721997
    [Abstract] [Full Text] [Related]

  • 2. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component.
    Lin YK, Leu YL, Yang SH, Chen HW, Wang CT, Pang JH.
    J Dermatol Sci; 2009 Jun; 54(3):168-74. PubMed ID: 19303259
    [Abstract] [Full Text] [Related]

  • 3. Indigo naturalis upregulates claudin-1 expression in human keratinocytes and psoriatic lesions.
    Lin YK, Chen HW, Leu YL, Yang YL, Fang Y, Su Pang JH, Hwang TL.
    J Ethnopharmacol; 2013 Jan 30; 145(2):614-20. PubMed ID: 23220199
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
    Lin YK, Wong WR, Chang YC, Chang CJ, Tsay PK, Chang SC, Pang JH.
    Dermatology; 2007 Jan 30; 214(2):155-61. PubMed ID: 17341866
    [Abstract] [Full Text] [Related]

  • 5. Evidence and potential mechanism of action of indigo naturalis and its active components in the treatment of psoriasis.
    Wang C, Yang P, Wang J, Liu L, Chen J, Cai X, Zhang M, Lin N, Wang S, Yu Y, Li L, Li X.
    Ann Med; 2024 Dec 30; 56(1):2329261. PubMed ID: 39316667
    [Abstract] [Full Text] [Related]

  • 6. The anti-TH17 polarization effect of Indigo naturalis and tryptanthrin by differentially inhibiting cytokine expression.
    Cheng HM, Kuo YZ, Chang CY, Chang CH, Fang WY, Chang CN, Pan SC, Lin JY, Wu LW.
    J Ethnopharmacol; 2020 Jun 12; 255():112760. PubMed ID: 32173427
    [Abstract] [Full Text] [Related]

  • 7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ, Di TT, Wang Y, Wang MX, Meng YJ, Lin Y, Xu XL, Li P, Zhao JX.
    Mol Immunol; 2018 Sep 12; 101():386-395. PubMed ID: 30064075
    [Abstract] [Full Text] [Related]

  • 8. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
    Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH.
    Arch Dermatol; 2008 Nov 12; 144(11):1457-64. PubMed ID: 19015420
    [Abstract] [Full Text] [Related]

  • 9. Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells.
    Chang HN, Huang ST, Yeh YC, Wang HS, Wang TH, Wu YH, Pang JH.
    J Ethnopharmacol; 2015 Nov 04; 174():474-81. PubMed ID: 26341616
    [Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils.
    Lin YK, Leu YL, Huang TH, Wu YH, Chung PJ, Su Pang JH, Hwang TL.
    J Ethnopharmacol; 2009 Aug 17; 125(1):51-8. PubMed ID: 19559779
    [Abstract] [Full Text] [Related]

  • 11. Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway.
    Yao Y, Li X, Yang X, Mou H, Wei L.
    Anticancer Agents Med Chem; 2024 Aug 17; 24(9):718-727. PubMed ID: 38347773
    [Abstract] [Full Text] [Related]

  • 12. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation.
    Hoesl C, Röhrl JM, Schneider MR, Dahlhoff M.
    Biochim Biophys Acta Gen Subj; 2018 Apr 17; 1862(4):958-966. PubMed ID: 29410073
    [Abstract] [Full Text] [Related]

  • 13. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.
    Arch Dermatol Res; 2008 Jan 17; 300(1):37-45. PubMed ID: 17960400
    [Abstract] [Full Text] [Related]

  • 14. A Review of Indigo Naturalis as an Alternative Treatment for Nail Psoriasis.
    McDermott L, Madan R, Rupani R, Siegel D.
    J Drugs Dermatol; 2016 Mar 17; 15(3):319-23. PubMed ID: 26954317
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis.
    Cheng HM, Wu YC, Wang Q, Song M, Wu J, Chen D, Li K, Wadman E, Kao ST, Li TC, Leon F, Hayden K, Brodmerkel C, Chris Huang C.
    BMC Complement Altern Med; 2017 Sep 02; 17(1):439. PubMed ID: 28865459
    [Abstract] [Full Text] [Related]

  • 16. Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial.
    Lin YK, See LC, Huang YH, Chi CC, Hui RC.
    Br J Dermatol; 2018 Jan 02; 178(1):124-131. PubMed ID: 28815560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation.
    Abu-Humaidan AH, Ananthoju N, Mohanty T, Sonesson A, Alberius P, Schmidtchen A, Garred P, Sørensen OE.
    J Immunol; 2014 Apr 01; 192(7):3355-64. PubMed ID: 24591374
    [Abstract] [Full Text] [Related]

  • 19. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
    Zhao J, Xie X, Di T, Liu Y, Qi C, Chen Z, Li P, Wang Y.
    Int Immunopharmacol; 2021 May 01; 94():107229. PubMed ID: 33611057
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.